Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 3 Biotechs Compete for the Same $108-Billion-Dollar Market
3 Biotechs Compete for the Same $108-Billion-Dollar Market
3 Biotechs Compete for the Same $108-Billion-Dollar Market
Submitted by
admin
on August 23, 2023 - 10:06am
Source:
Motley Fool
News Tags:
NASH
Madrigal Pharmaceuticals
Terns Pharmaceuticals
Viking Therapeutics
Headline:
3 Biotechs Compete for the Same $108-Billion-Dollar Market
snippet:
Many drug developers are pursuing therapies for those who supper from NASH.
Madrigal Pharmaceuticals is waiting on the FDA's decision for its drug right now.
Terns Pharmaceuticals and Viking Therapeutics are better capitalized at the moment.
Do Not Allow Advertisers to Use My Personal information
